Genix Pharmaceuticals Corporation reported earnings results for the second quarter and six months ended April 30, 2022. For the second quarter, the company reported net loss was CAD 0.227517 million compared to CAD 0.402271 million a year ago.
For the six months, net loss was CAD 0.566013 million compared to CAD 0.795508 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.